Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Vasocon-a Generic Name & Formulations
Legal Class
OTC
General Description
Antazoline phosphate 0.5%, naphazoline HCl 0.05%; oph. soln; contains benzalkonium chloride.
Pharmacological Class
Vasoconstrictor.
How Supplied
Soln—15mL
Manufacturer
Vasocon-a Indications
Indications
Temporary relief of ocular redness and itching.
Vasocon-a Dosage and Administration
Adults and Children
<6yrs: not recommended. ≥6yrs: 1–2 drops up to 4 times daily.
Vasocon-a Contraindications
Contraindications
Narrow-angle glaucoma. Concurrent MAOIs. Contact lens wear.
Vasocon-a Boxed Warnings
Not Applicable
Vasocon-a Warnings/Precautions
Warnings/Precautions
Avoid prolonged use. Hypertension. Cardiovascular disease. Urinary hesitancy. Diabetes. Pregnancy. Nursing mothers.
Vasocon-a Pharmacokinetics
See Literature
Vasocon-a Interactions
Interactions
Hypertensive crisis with MAOIs.
Vasocon-a Adverse Reactions
Adverse Reactions
Mydriasis, increased IOP, local irritation, allergic dermatitis, sensitization, systemic effects if absorbed, may precipitate narrow-angle glaucoma.
Vasocon-a Clinical Trials
See Literature
Vasocon-a Note
Not Applicable
Vasocon-a Patient Counseling
See Literature
